Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in different specimens.
The sensitivity of screening for methicillin-resistant Staphylococcus aureus (MRSA) can be improved by adding other specimen sites to nares. We describe an evaluation of a new selective medium, BBL CHROMagar MRSA II (CMRSAII), for its ability to detect MRSA from different specimen types. CMRSAII is a chromogenic medium which incorporates cefoxitin for the detection of MRSA. A study was performed at four clinical laboratories with the following specimens: 1,446 respiratory, 694 stool, 1,275 skin, and 948 wound specimens and 688 blood culture bottles containing Gram-positive cocci. The recovery of MRSA on traditional culture media was compared to results with CMRSAII. S. aureus was tested by cefoxitin disk diffusion. CMRSAII was interpreted as positive for MRSA at 24 h (range, 18 to 28 h) based solely on the visualization of mauve-colored colonies and at 48 h (range, 36 to 52 h) based on detection of mauve colonies with subsequent confirmation as S. aureus (by coagulase or latex agglutination testing). MRSA was recovered more frequently on CMRSAII (89.8% at 24 h and 95.6% at 48 h) than on traditional culture plates (83.1% at 24 h and 79.8% at 48 h) for all specimen types combined (P < 0.001). The percent sensitivities of CMRSAII at 24- and 48-h reads, respectively, were 85.5 and 92.4% for respiratory specimens, 87.9% and 98.3% for stool specimens, 88.4% and 96.1% for skin specimens, 92.1% and 94.6% for wound specimens, and 100% and 100% for positive blood cultures. The specificity was 99.8% for respiratory specimens and 100% for all others. In conclusion, CMRSAII is a reliable screening medium for multiple specimen types.
Wendt
C
C
Hygiene-Institut, University of Heidelberg, INF 324, 69 120 Heidelberg, Germany. Constanze.Wendt@labor-limbach.de
Havill
N L
NL
Chapin
K C
KC
Boyce
J M
JM
Dickenson
R
R
Eigner
U
U
Schütt
S
S
Fahr
A M
AM
D001431:Bacteriological Techniques / Q000379:methods*; D001769:Blood / Q000382:microbiology; D003470:Culture Media / Q000737:chemistry*; D005243:Feces / Q000382:microbiology; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D012137:Respiratory System / Q000382:microbiology; D012680:Sensitivity and Specificity; D012867:Skin / Q000382:microbiology; D013203:Staphylococcal Infections / Q000175:diagnosis*; D014947:Wounds and Injuries / Q000382:microbiology
D003470:Culture Media
J Clin Microbiol. 2005 Nov;43(11):5536-40
16272482
Diagn Microbiol Infect Dis. 2007 Nov;59(3):319-23
17913436
Infect Control Hosp Epidemiol. 2008 Oct;29 Suppl 1:S62-80
18840090
J Hosp Infect. 2009 Apr;71(4):373-4
19215999
J Med Microbiol. 2007 Apr;56(Pt 4):491-494
17374889
J Clin Microbiol. 2004 Oct;42(10):4519-23
15472303
J Clin Microbiol. 2006 Dec;44(12):4561-3
17050808
J Clin Microbiol. 2007 Aug;45(8):2486-90
17537949
J Clin Microbiol. 2006 Jul;44(7):2575-6
16825383
J Clin Microbiol. 2009 Mar;47(3):566-8
19144795
J Clin Microbiol. 2008 May;46(5):1577-87
18322065
J Clin Microbiol. 2006 Feb;44(2):637-9
16455933
J Hosp Infect. 2002 Jul;51(3):189-200
12144798
Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):47-53
18663499
Am J Infect Control. 2007 Mar;35(2):73-85
17327185
J Hosp Infect. 2008 Aug;69(4):315-20
18602183
J Hosp Infect. 2006 May;63 Suppl 1:S1-44
16581155
J Clin Pathol. 2008 Jul;61(7):841-3
18413653
Clin Microbiol Infect. 2006 Dec;12(12):1168-74
17121622
Euro Surveill. 2008 Nov 13;13(46):
19021951
Intensive Care Med. 2008 Sep;34(9):1703-6
18500421
J Med Microbiol. 2007 Apr;56(Pt 4):500-503
17374891
Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):363-9
18855028
J Clin Microbiol. 2007 Jan;45(1):154-8
17093032
J Hosp Infect. 2008 Dec;70(4):388-9
18977554
J Med Microbiol. 2007 Jan;56(Pt 1):43-46
17172515
J Clin Microbiol. 2008 Apr;46(4):1174-7
18234863